Boltz develops frontier models and intelligent agents to accelerate drug discovery and reshape biology. They combine computational methods to enable hit identification, lead optimization, and protein design, with a focus on distributed screening and iterative refinement across large chemical spaces. Their work spans computational biology and medicinal chemistry, operating globally with resources like Boltz Lab for hands-on experimentation and collaboration. The company emphasizes building better molecules through AI-inspired approaches to accelerate biology-driven research.